| Active ingredient (INN) | Febuxostat |
|---|---|
| Brand names | Auro-Febuxostat |
| ATC level 5 | M04AA03 |
| ATC level 4 | M04AA |
| Therapeutic category | Auto-created by Health Canada — Drug Shortages Database scraper |
| Controlled substance | No |
| Marketing-authorisation holders | TILLOMED LABORATORIES LIMITED, Hikma Pharmaceuticals USA Inc, A Menarini Australia Pty Ltd |
| Registrations on file | 5 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| FEBUXOSTAT 80 MG FILM-COATED TABLETS | 80 MG | tablet | 🇬🇧 GB | TILLOMED LABORATORIES LIMITED | Active |
| FEBUXOSTAT 120 MG FILM-COATED TABLETS | 120 MG | tablet | 🇬🇧 GB | TILLOMED LABORATORIES LIMITED | Active |
| Febuxostat | 40mg/1 | tablet | 🇺🇸 US | Hikma Pharmaceuticals USA Inc | Active |
| Febuxostat | 80mg/1 | tablet | 🇺🇸 US | Hikma Pharmaceuticals USA Inc | Active |
| ADENURIC febuxostat | 80 mg | — | 🇦🇺 AU | A Menarini Australia Pty Ltd | Active |